<p>Drift opportunity for scenario C with targeted distribution of a vaccine stockpile sufficient for 50 per cent coverage and assuming that pre-vaccination <i>R</i><sub>eff</sub> = 2. The axis labelled <i>ϵ</i><sub>v</sub> indicates the relative infectiousness of vaccinated and unvaccinated naïve hosts and “exp coverage” indicates the fractional vaccine coverage in experienced hosts (vaccine distribution is random when exp coverage is 0.5). Each panel corresponds to a different assumption regarding the form for the per infection rate of antigenic emergence <i>g</i><sub>0,<i>i</i></sub>; equal probability per infection (<i>left</i>), proportional to host infectiousness (<i>middle</i>), and zero for vaccinated hosts with existing CTL protecti...
<p>Given population density, 60 simulation replicates were run for each vaccination diffusion rate <...
, and have been calibrated for such settings. Their applicability to low transmission settings is un...
Escape mutations (EM) to SARS-Cov-2 have been detected and are spreading. Vaccines may need adjustme...
<p><b>Upper panels:</b> drift opportunity relative to an unimpeded epidemic as a function of general...
<p>Predicted attack rates for four different pandemic and vaccine action scenarios as a function of ...
<p>(A) Five stochastic simulations of Muizenberg Mathematical Fever outbreaks using transmission par...
<p>Lines show the proportion of the host population infected at a particular time, and each panel sh...
<p><b>a. Estimates for predicted probability of participation; values for a mild outbreak.</b> Notes...
<p>The stochastic combined mean final epidemic size 〈<i>E</i>〉 as a function of the fractional alloc...
<p>Panel A shows the number of susceptibles and infecteds during an outbreak with <i>R</i><sub>0</su...
Left: Distributions of cumulative infections over the 70-day training period across 1,000 replicate ...
<div><h3>Background</h3><p>Many novel vaccines can cover only a fraction of all antigenic types of a...
<p>Field estimate (vertical axis) represents the vaccine effectiveness estimate derived from empiric...
<p>Panel (a) presents epidemic durations under the baseline and annual vaccination (AV) strategies. ...
Influenza in humans is characterised by strongly annual dynamics and antigenic evolution leading to ...
<p>Given population density, 60 simulation replicates were run for each vaccination diffusion rate <...
, and have been calibrated for such settings. Their applicability to low transmission settings is un...
Escape mutations (EM) to SARS-Cov-2 have been detected and are spreading. Vaccines may need adjustme...
<p><b>Upper panels:</b> drift opportunity relative to an unimpeded epidemic as a function of general...
<p>Predicted attack rates for four different pandemic and vaccine action scenarios as a function of ...
<p>(A) Five stochastic simulations of Muizenberg Mathematical Fever outbreaks using transmission par...
<p>Lines show the proportion of the host population infected at a particular time, and each panel sh...
<p><b>a. Estimates for predicted probability of participation; values for a mild outbreak.</b> Notes...
<p>The stochastic combined mean final epidemic size 〈<i>E</i>〉 as a function of the fractional alloc...
<p>Panel A shows the number of susceptibles and infecteds during an outbreak with <i>R</i><sub>0</su...
Left: Distributions of cumulative infections over the 70-day training period across 1,000 replicate ...
<div><h3>Background</h3><p>Many novel vaccines can cover only a fraction of all antigenic types of a...
<p>Field estimate (vertical axis) represents the vaccine effectiveness estimate derived from empiric...
<p>Panel (a) presents epidemic durations under the baseline and annual vaccination (AV) strategies. ...
Influenza in humans is characterised by strongly annual dynamics and antigenic evolution leading to ...
<p>Given population density, 60 simulation replicates were run for each vaccination diffusion rate <...
, and have been calibrated for such settings. Their applicability to low transmission settings is un...
Escape mutations (EM) to SARS-Cov-2 have been detected and are spreading. Vaccines may need adjustme...